Cyteir Therapeutics (CYT)
US Market

Cyteir Therapeutics (CYT) Financial Statements


Cyteir Therapeutics Financial Overview

Cyteir Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.932; its P/E ratio is -3.23; Cyteir Therapeutics is scheduled to report earnings on May 2, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue----$ 0.00
Gross Profit-----
EBIT$ -3.53M$ -8.40M$ -14.02M$ -8.79M$ -11.76M
EBITDA$ -3.43M$ -8.30M$ -13.82M$ -8.59M$ -11.59M
Net Income Common Stockholders$ -3.53M$ -8.40M$ -12.48M$ -8.79M$ -11.04M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 129.24M$ 133.63M$ 137.20M$ 147.12M$ 153.89M
Total Assets$ 131.01M$ 134.39M$ 138.98M$ 153.23M$ 161.70M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 900.00K
Net Debt$ -129.24M$ -133.63M$ -137.20M$ -147.12M$ -152.99M
Total Liabilities$ 5.98M$ 6.60M$ 4.00M$ 6.95M$ 7.66M
Stockholders Equity$ 125.03M$ 127.79M$ 134.98M$ 146.29M$ 154.03M
Cash Flow-
Free Cash Flow$ -4.56M$ -4.00M$ -9.97M$ -6.92M$ -12.58M
Operating Cash Flow$ -4.56M$ -4.16M$ -10.12M$ -6.92M$ -12.57M
Investing Cash Flow-$ 153.00K$ 150.00K-$ -10.00K
Financing Cash Flow$ 164.00K$ 428.00K$ 103.00K$ 147.00K$ 71.00K
Currency in USD

Cyteir Therapeutics Earnings and Revenue History

Cyteir Therapeutics Debt to Assets

Cyteir Therapeutics Cash Flow

Cyteir Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis